Upgrade to SI Premium - Free Trial

Sanofi (SNY) Insulin Glargine + Lixisenatide NDA Accepted by FDA

February 22, 2016 8:04 AM
Sanofi (NYSE: SNY) announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles